BiocellT retweeted
New analytical method provides an insight into additional chromosomes bit.ly/2HPuVKx
BiocellT retweeted
Switzerland waits an estimated 157 days longer than the EU to receive new drugs - even with a series of bilateral agreements.
To ensure patients have prompt access to life-saving medicines, the UK must keep the closest possible relationship with the European Union.
BiocellT retweeted
A look at the applications -- and caveats -- for CancerSEEK: scim.ag/2HztJuB
BiocellT retweeted
"European science has to involve all of the European countries"
We spoke to over 200 people from organisations across #Europe to hear their ideas on the future of #EU 🇪🇺 and #UK 🇬🇧 science.
See what they said ⬇️ and read the full report here: wellcome.ac.uk/news/bolster-…
The future of UK/EU science post-Brexit
BiocellT retweeted
En #France, de 2008 à 2014, le nombre de publications dans les revues prestigieuses a augmenté de plus de 50%. Nous avons démontré que la France a de plus en plus d’entrepreneurs-chercheurs ambitieux et dynamiques >> ow.ly/Hcpf30i3yv3 @FranceBiotech #LetsgoFrance #biotech
BiocellT retweeted
What you need to know about how EU #medtech regulatory is shaping up in 2018 bit.ly/2CR6n50 @MedtechAmanda #MTF2018
BiocellT retweeted
8 amazing startups, and one winner from @JNJInnovation, @EBDgroup. Check out who got first place at #BioEurope #StartupSlam17! Watch full video: goo.gl/QZnAEP
BiocellT retweeted
E-santé : les nouvelles tendances découvertes au CES 2018 bit.ly/2DiWUmj
BiocellT retweeted
Really useful best practice guide from @BIA_UK for the life sciences sector - particularly relevant with MiFID II in play. Great that @Instinctif_LS could be part of the core team helping the sector. xitter.cf/Instinctif_LS/status/9…
.@InstinctifPtnrs welcomes publication of new @BIA_UK best practice guide for communicating #R&D progress to investors & the public. #lifesciences Managing Partner and BIA Board Member @mrssuecharles was part of the core team that developed the guide bia.me/RDcommsguide
BiocellT retweeted
Super proud of the @TheScientistLLC team for its work on our January 2018 issue, which delves into the unsettled (and unsettling) science of pain. bit.ly/2CyLmJa
BiocellT retweeted
[Replay 2017] Retour sur 6 faits marquants dans le monde médical (thérapie génique, chirurgie de l'extrême, opération en réalité augmentée, ...) topsante.com/medecine/votre-…
BiocellT retweeted
[Panorama 2017] En Europe : plus de 3 000 biotechs et 25 000 medtechs médicales bit.ly/FBT1212
BiocellT retweeted
Lancement d'une vaste étude sur l'immunothérapie dans le cancer du poumon sciencesetavenir.fr/sante/pi… via @Sciences_Avenir
BiocellT retweeted
BIA reaction to @EMA_News relocation - Businesses now need certainty. The best way to do this is by an early agreement to a transition time frame and continued close regulatory co-operation bia.me/2hFXG0l #brexit #medicinesregulation
BiocellT retweeted
Amsterdam will be the new location of the European Medicines Agency
Background info on the relocation of the UK-based EU agencies: consilium.europa.eu/en/polic…
BiocellT retweeted
Patients need rest not antibiotics - overuse makes infections harder to treat says @PHE_uk #StopSuperbugs wellc.me/2zusDf3
BiocellT retweeted
New gene editing technique for neurons could boost research in brain diseases dlvr.it/Pwhm6G
BiocellT retweeted
#Innovation in the field of #medtech fusing with music & art. Register to the #ArtofLife event in the @Europarl_EN : bit.ly/2xQs138





























